Patents Assigned to Xiamen Bioway Biotech Co., Limited
  • Anti-cancer bioactive peptides isolated from crude venom of Xinjiang
    Patent number: 8207122
    Abstract: An anti-cancer bioactive peptide having an amino acid sequence as shown in SEQ ID NO.1, or a functional analogue thereof prepared by substitution, insertion, or deletion of one or more amino acids of SEQ ID NO. 1, or a peptide having 90% homology in amino acid sequence with that of SEQ ID NO. 1. The anti-cancer bioactive peptide of the invention can selectively kill cancer cells and exhibit low cytotoxicity against normal cells.
    Type: Grant
    Filed: February 1, 2010
    Date of Patent: June 26, 2012
    Assignee: Xiamen Bioway Biotech Co., Limited
    Inventors: Songping Liang, Zhonghua Liu